• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Nintedanib (As Esliate)
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    Boehringer Ingelheim
    partial basket chart

    Non-Receptor Tyrosine Kinases Inhibitor, Receptor Tyrosine Kinases. Nintedanib (As Esliate) 100 mg, 150 mg.
    CAPS.: 100mg×30, 60, 150mg×60.
    Conduct liver funct. tests prior to init. tmt.
    The recom. dosage 150 mg ×2/d admin. approx. 12 hrs. apart.
    Caps. should be taken with food and swallowed whole with liquid.
    Do not exceed the recom. max. dly. dosage of 300 mg. See lit.
    Tmt. of idiopathic pulmon. fibrosis in adults.
    C/I: Hypersens.